Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation
Alison M. Weppler, Laetitia Da Meda, Inês Pires da Silva, Wen Xu, Giovanni Grignani, Alexander M. Menzies, Matteo S. Carlino, Georgina V. Long, Serigne Lo, Ina Nordman, Christopher Steer, Megan Lyle, Claudia Trojaniello, Paolo A. Ascierto, Célèste Lebbé, Shahneen Sandhu
Topics & Concepts
MedicineDiscontinuationInternal medicineProgressive diseaseGastroenterologyProgression-free survivalSurgeryMerkel cell carcinomaToxicityClinical endpointOncologyCarcinomaChemotherapyRandomized controlled trialPolyomavirus and related diseasesMultiple Sclerosis Research StudiesBacteriophages and microbial interactions